✦ LIBER ✦

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

✍ Scribed by Hochster, H. S.; Hart, L. L.; Ramanathan, R. K.; Childs, B. H.; Hainsworth, J. D.; Cohn, A. L.; Wong, L.; Fehrenbacher, L.; Abubakr, Y.; Saif, M. W.; Schwartzberg, L.; Hedrick, E.

Book ID: 126716625
Publisher: American Society of Clinical Oncology
Year: 2008
Tongue: English
Weight: 149 KB
Volume: 26
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2007.15.4138

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

615 POSTER Safety, tolerability and effi

615 POSTER Safety, tolerability and efficacy of the addition of bevacizumab to oxaliplatin/fluoropyrimidine regimens as first-line treatment of metastatic colorectal cancer (mCRC): Results of TREE 2 cohort of the TREE study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Safety and efficacy of first-line bevaci

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB

A retrospective observational study on t

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

Fluorouracil, Leucovorin, and Oxaliplati

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

✍ Bokemeyer, C.; Bondarenko, I.; Makhson, A.; Hartmann, J. T.; Aparicio, J.; de Br 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 201 KB

Fluorouracil, Leucovorin, and Oxaliplati

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

✍ Bokemeyer, C.; Bondarenko, I.; Makhson, A.; Hartmann, J. T.; Aparicio, J.; de Br 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 201 KB

## Purpose This randomized study assessed whether the best overall response rate (ORR) of cetuximab combined with oxaliplatin, leucovorin, and fluorouracil (FOLFOX-4) was superior to that of FOLFOX-4 alone as first-line treatment for metastatic colorectal cancer. The influence of KRAS mutation sta

A phase I trial of vandetanib combined w

A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer

✍ Elwyn C. Cabebe, George A. Fisher, Branimir I. Sikic 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 112 KB